Clinical Trials Update: Jan. 28, 2008
Alzheimer's Disease Brain Cancer Hepatitis B
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
If you are aged 55 to 90, have a caretaker, and have mild-to-moderate Alzheimer's disease, you may qualify for this study.
The research site is in Sun City, Ariz.
If you are at least 18 and have been diagnosed with primary brain cancer, you may be eligible for this study.
The research site is in New York City.
If you are a black or Hispanic adult aged 18 to 70 and have been diagnosed with chronic hepatitis B, you may be eligible for this study.
The research site is in Boston, Mass.
Copyright 2008 Thomson CenterWatch. All rights reserved.